Healthcare Industry Today
sign up now for free trial
FORMATS: RSS | EMAIL | MOBILE

Latest Heart Valve Disease News

  • Cholesterol drug Vytorin fails new trial Schering-Plough, Merck shares... 23 Jul 2008 13:51 GMT
    ... the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for ...

  • Winston's Jay Starr shines after bilateral lung... 23 Jul 2008 13:32 GMT
    ... brother, Steve, was diagnosed with the hereditary disease. Steve Starr died in 1989, when he ... tissues that can be donated include the heart, pancreas, bone, kidneys, corneas, skin, lungs, liver, ... skin, lungs, liver, intestine, connective tissue, heart valves, veins and the entire body for medical ...

  • Schering-Plough, Merck's Vytorin Misses Study Goal - July 22, 2008 23 Jul 2008 04:53 GMT
    ... the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for ...

  • Rising oil prices weigh on US stocks 23 Jul 2008 04:50 GMT
    ... cent after a study showed that cholesterol drug failed to reduce the risk of heart valve disease in a study. Schering-Plough sank 12.3 per cent to $18.80 while Merck fell 3.5 ...

  • Cholesterol drug fails another test 23 Jul 2008 04:45 GMT
    ... of improving cardiovascular outcomes in a closely-watched heart study. No significant difference in the study's ... patients with irregular thickening of the main valve to the aorta were broken into two ... other secondary measure of reducing aortic valve disease events - the need for surgical valve ...

  • Read "Losing Weight wasn't worth taking Fen-Phen: PPH was the Outcome" 23 Jul 2008 03:30 GMT
    ... breathing problems or any issues with my heart. I was a nursing assistant and we ... Sure enough, I was diagnosed with the disease. I finally got on disability after I ... $34,000; my sister was diagnosed with mitral valve regurgitation. She now lives in Tucson but ...

  • US doctors push for unapproved medical devices 23 Jul 2008 02:31 GMT
    ... their families to his native Jordan for heart operations using medical devices that are not ... adults because the market is bigger. Heart diseases in children, for example, are more likely ... Lifesciences, the world's biggest maker of heart valves, is one example of a public company ...

  • Vytorin report hits Merck, Schering 23 Jul 2008 00:31 GMT
    ... results for Vytorin, a costly, heavily advertised cholesterol drug, when it came to treating heart-valve disease. Shares of the pharmaceutical companies that market the drug together -- Merck & Co. ...

  • Winston's Jay Starr shines after bilateral lung transplant 22 Jul 2008 23:31 GMT
    ... brother, Steve, was diagnosed with the hereditary disease. Steve Starr died in 1989, when he ... tissues that can be donated include the heart, pancreas, bone, kidneys, corneas, skin, lungs, liver, ... skin, lungs, liver, intestine, connective tissue, heart valves, veins and the entire body for medical ...

  • Edwards Lifesciences Reports Strong Second Quarter Results and Raises Full Year Outlook 22 Jul 2008 20:31 GMT
    ... products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ... the strong uptake of our Edwards SAPIEN valve inEurope where procedural success continues to be ... For the second quarter, the company reported Heart Valve Therapy sales of , a 23.8 ...

  • More Disappointing Results For Vytorin 22 Jul 2008 18:34 GMT
    ... general - when it comes to and heart disease. Merck has released another series of their ... is not good for people with heart valve disease. , does not appear to slow ...

  • Dealing with a fainting spell 22 Jul 2008 17:50 GMT
    ... Syncope is really a symptom, not a disease, so evaluation for the underlying cause is ... system causes blood pressure to drop and heart rate to decrease leading to cerebral hypoperfusion ... hypertrophic subaortic stenosis (IHSS) or certain heart valve problems. Cardiac syncope is a marker of ...

  • Merck shares way down, Schering's recover from early drop after negative Vytorin study 22 Jul 2008 17:31 GMT
    ... Merck's Zocor and Schering-Plough's Zetia, didn't prevent deterioration, surgery or death in patients with diseased heart valves, as hoped. Study patients on the drug also had far more cancers and cancer ...

  • Merck shares way down, Schering recovering 22 Jul 2008 17:31 GMT
    ... Merck's Zocor and Schering-Plough's Zetia, didn't prevent deterioration, surgery or death in patients with diseased heart valves, as hoped. Study patients on the drug also had far more cancers and cancer ...

  • AP Health NewsBrief at 10:06 a.m. EDT 22 Jul 2008 14:25 GMT
    ... as a packing house. Quest: Repairing more hearts with implanted pumpsWASHINGTON (AP) _ When it ... major European study in patients with heart valve disease found the drug didn't prevent worsening of ...

  • More Vytorin Studies Released 22 Jul 2008 13:58 GMT
    ... part of their studies today and the new is not good for people with heart valve disease. Vytorin, a combination of , does not appear to slow the progression of aortic ...

  • New Jersey: Cholesterol pill fails to lower risks 22 Jul 2008 13:57 GMT
    ... latest disappointment for the cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for ...

  • Vytorin fails to meet main goal of heart study 22 Jul 2008 13:17 GMT
    ... Vytorin fails to meet main goal of heart study NEW YORK (Reuters) - The cholesterol ... patients with irregular thickening of the main valve to the aorta were broken into two ... benefits in reducing risk of coronary artery disease in the study. The drug was no ...

  • Cholesterol drug Vytorin fails new trial 22 Jul 2008 13:15 GMT
    ... the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for ...

  • Study Finds No Significant Difference Between Vytorin and Placebo 22 Jul 2008 12:56 GMT
    ... used for the treatment of high cholesterol, failed to prevent the worsening of cholesterol disease or to lower the need for surgery in those patients with heart valve disease. The often deadly condition, becoming increasingly popular among elderly people, involves partial blockage ...

  • Intensified Concerns on Vytorin 22 Jul 2008 12:16 GMT
    ... 2008 In a clinical trial, the cholesterol-lowering drug Vytorin did not help people with heart-valve disease avoid further heart problems but did appear to increase their risk of cancer, scientists ...

  • Vytorin fails to meet main goal in SEAS study, cancer link dismissed 22 Jul 2008 11:07 GMT
    ... which involves partial blockage of the aortic valve in the heart. No significant difference was observed between Vytorin ... for the secondary endpoint of aortic valve disease events alone, although patients who received Vytorin ...

  • Vytorin fails study goal 22 Jul 2008 10:35 GMT
    ... Vytorin doesn't lower the risk of major heart valve problems and need for related surgical procedures, ... a secondary goal of improving aortic valve disease events, which included valve replacement surgery, hospitalization ...

  • Results From The SEAS (Simvastatin And Ezetimibe In Aortic Stenosis) Study 22 Jul 2008 10:32 GMT
    ... in patients with aortic stenosis. Aortic stenosis (which involves partial blockage of the aortic valve in the heart) is a relatively common disease among older people in Western populations. Left untreated, it can progress to death from ...

  • Trial Intensifies Concerns About Safety of Vytorin 22 Jul 2008 09:54 GMT
    ... In a clinical trial, the cholesterol-lowering drug Vytorin did not help people with heart-valve disease avoid further heart problems but did appear to increase their risk of cancer, scientists ...

  • Schering-Plough, Merck Vytorin Misses Study Goal Of Reducing Heart Valve Risks 22 Jul 2008 09:26 GMT
    ... July 22, 2008 (FinancialWire) The preliminary results of a European study of patients with heart valve disease showed that cholesterol drug Vytorin, marketed jointly by Merck & Co. (NYSE: MRK) and ...

  • Cholesterol drug Vytorin fails study goal 22 Jul 2008 08:18 GMT
    ... Vytorin doesn't lower the risk of major heart valve problems and need for related surgical procedures, ... a secondary goal of improving aortic valve disease events, which included valve replacement surgery, hospitalization ...

  • Vytorin didn't help heart valve disease, study reports 22 Jul 2008 07:27 GMT
    ... the latest disappointment over cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for ...

  • National And International Report / Roche offers $43.7 billion for rest of Genentech 22 Jul 2008 07:07 GMT
    ... Vytorin doesn't lower the risk of major heart valve problems and the need for related surgical ... a secondary goal of improving aortic valve disease events, which included valve replacement surgery, hospitalization ...

  • Schering-Plough stock plunges 12% 22 Jul 2008 07:06 GMT
    ... condition in which blood flow to the heart is blocked, The Associated Press reported. The ... more than 5 million Americans have the disease to some extent. It's the No. 2 ... goal of reducing events such as heart valve replacement surgery. On the plus side, Vytorin ...

  • AP Health NewsBrief at 1:47 a.m. EDT 22 Jul 2008 06:19 GMT
    ... as a packing house. Quest: Repairing more hearts with implanted pumpsWASHINGTON (AP) _ When it ... major European study in patients with heart valve disease found the drug didn't prevent worsening of ...

  • Body language: Translate creaks and cracks into better health 22 Jul 2008 06:12 GMT
    ... point to hyper- thyroidism or an autoimmune disease, like lupus. • For mild dryness, preservative-free ... involves scarring of the lungs) or a heart-valve problem can also trigger coughing if fluid ...

  • Cholesterol drug Vytorin fails new trial / Schering-Plough, Merck shares sink on heart valve study results 22 Jul 2008 05:54 GMT
    ... the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for ...

  • PRESS DIGEST - New York Times business news - July 22 22 Jul 2008 05:51 GMT
    ... * In a clinical trial, the cholesterol-lowering drug Vytorin did not help people with heart-valve disease avoid further heart problems but did appear to increase their risk of cancer, scientists ...

  • Schering Plough Corp. Q2 2008 Earnings Call Transcript 22 Jul 2008 05:23 GMT
    ... stenosis that is hard or poorly functioning heart valves. Many of you may also been listening ... the rate of progression of aortic valve disease. And I was encouraged by the comments ...


1 - 35 / 302      NEXT >>>

NOT SATISFIED WITH THIS HEART VALVE DISEASE NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
REACH 1,000,000 READERS A MONTH! ADVERTISE HERE
 

Take This Poll

Regardless of your general preferences, which U.S. presidential candidate's Iraq policy do you support? (Jul. 15, 2008)



 

EIN News Copyright © 2005-2008 IPD Group, Inc. All Rights Reseved. | User Agreement | Privacy Policy | Contact